Back to Journals » Vascular Health and Risk Management » Volume 13 Juan Carlos Yugar-Toledo,1 Rodrigo Modolo,2 Ana Paula de Faria,2 Heitor Moreno2 1São José do Rio Preto Medicine School – FAMERP, São José do Rio Preto, 2School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil Abstract: Mineralocorticoid-receptor antagonists

As it is now, newborns with pulmonary hypertension have their oxygenation improved using bulky tanks or regulators that are quite expensive. Pulmonary hypertension (PH or PHTN) is an increase in blood pressure in the arteries of the lungs. Symptoms include, shortness of breath, tiredness, chest pain, swelling of the legs